Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 104180-18-9 |
|---|---|
| Purity | ≥95% |
| Formula | C27H43N3O5S |
| Formula Wt. | 565.74 |
| Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
May be useful against COVID-19
Polyphenolic compound present in black tea.
Venlafaxine metabolite; SERT and NET inhibitor....
Immunodominant peptide epitope occurring in mul...
Dihydrofolate reductase inhibitor.
Inhibitor of PI3K.
Mycotoxin; F1F0 ATP synthase inhibitor.
Wip1 inhibitor.
Synthetic non-steroid endocrine disrupter; ER a...
Found in Aristolochia and Radix; PLA2 inhibitor...
Nitrosourea, DNA alkylator.
JAK1 inhibitor.
HIV protease inhibitor, SERCA inhibitor.
Triterpene saponin originally found in Bolboste...
Endogenous bombesin-like peptide, involved in f...
Aldose reductase inhibitor.
Adenosine A2A agonist.
Cholesterol ester transfer protein inhibitor.
Benzothiazole; TRPC5 agonist, PTR1 inhibitor, v...
FGFR inhibitor.